EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.

'Quinazoline small' compounds, including erlotinib, sapitinib and gefitinib, exerted activity on U‐CH1, U‐CH7 and MUG‐Chor1 and showed a trend to greater potency than 'quinazoline large' compounds (Table 2 ).

also in 53,322 other papers